Relations between epidermal barrier dysregulation and Staphylococcus species– dominated microbiome dysbiosis in patients with atopic dermatitis  Can Altunbulakli,

Slides:



Advertisements
Similar presentations
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Advertisements

Anti–IL-23A mAb BI for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose,
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology  Saakshi Khattri, MD, Avner.
Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence  Mariya Rozenblit, BA, Mayte Suarez-Farinas,
Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma  Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,
Mechanisms of IFN-γ–induced apoptosis of human skin keratinocytes in patients with atopic dermatitis  Ana Rebane, PhD, Maya Zimmermann, PhD, Alar Aab,
Induced sputum proteome in healthy subjects and asthmatic patients
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications  Mayte.
Asthma inflammatory phenotypes show differential microRNA expression in sputum  Tania Maes, PhD, Francisco Avila Cobos, MSc, Florence Schleich, MD, PhD,
An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis  Amy S. Paller, MD, MS, Yael Renert-Yuval, MD, Maria Suprun, MPH,
Transcriptome analysis of proton pump inhibitor–responsive esophageal eosinophilia reveals proton pump inhibitor–reversible allergic inflammation  Ting.
Donald Y.M. Leung, MD, PhD, Emma Guttman-Yassky, MD, PhD 
Atopic dermatitis: Age and race do matter!
Epithelial proteome profiling suggests the essential role of interferon-inducible proteins in patients with allergic rhinitis  Joseph Ndika, PhD, Liisa.
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
The Editors' Choice Journal of Allergy and Clinical Immunology
Inflammatory marker analysis in psoriatic skin under topical phosphodiesterase 4 inhibitor treatment  Lennart M. Roesner, PhD, Petra Kienlin, Gabriele.
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3  Kevin O. Kisich, PhD, Charles.
Persistence of the IgE repertoire in birch pollen allergy
Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease  Alex Poole, MS, Cydney Urbanek, BS, Celeste Eng, BS, Jeoffrey.
Anti–IL-23A mAb BI for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose,
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling  David Bending, PhD,
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis  James G. Krueger, MD, Scott Fretzin, MD, Mayte Suárez-Fariñas,
Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma  Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response  Suzanne Tintle, BS, Avner Shemer, MD, Mayte Suárez-Fariñas,
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing.
IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids  Carine Blanchard, PhD, Melissa K. Mingler,
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling  David A. Ewald, MSc, Shinji.
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells  Kristine E. Nograles, MD,
Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with.
Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps  Can Altunbulakli, MSc, Rita Costa,
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing  Mayte Suárez-Fariñas, PhD, Benjamin Ungar,
Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures  Huei-Chi.
Small RNA profiling reveals deregulated phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway in bronchial smooth muscle.
Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation  David F. Choy, BS, Daniel K. Hsu, PhD,
An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation  Teresa Song, BS, Ana B. Pavel, PhD, Huei-Chi Wen, MD, PhD,
Lower airway microbiota and mycobiota in children with severe asthma
A network-based analysis of the late-phase reaction of the skin
Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism  Emma Guttman-Yassky, MD, PhD, Benjamin Ungar, BA, Shinji Noda, MD, PhD, Maria.
Anti–IL-23A mAb BI for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose,
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid  Jeffrey B. Travers, MD, PhD, Amal Kozman, MD, Nico Mousdicas, MD,
Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1  Huan Zhang, MD, PhD, Colm E. Nestor, PhD, Shuli Zhao, PhD,
An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: Integration of machine learning  Benjamin F. Sallis, BS, Lena Erkert,
Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2–high atopic dermatitis disease endotype  Nathan Dyjack,
Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis  Shunya Mashiko, BPharm, Salim Bouguermouh, MD, PhD, Manuel.
The airway microbiome in patients with severe asthma: Associations with disease features and severity  Yvonne J. Huang, MD, Snehal Nariya, BS, Jeffrey.
Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis  Emma Guttman-Yassky, MD, MSc, Michelle.
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis  Thomas Werfel, MD, Jean-Pierre Allam, MD, Tilo Biedermann, MD, Kilian.
Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome  Vibhav Sekhsaria, MS,
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
Altered metabolic profile in patients with IgE to galactose-alpha-1,3-galactose following in vivo food challenge  John W. Steinke, PhD, Shawna L. Pochan,
The Editors' Choice Journal of Allergy and Clinical Immunology
Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases  Nikhil Dhingra, BS, Mayte.
IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy  Helen A. Brough, MSc, FRCPCH, David J. Cousins,
Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis  Marie Tauber, MD, Stefana.
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
New pathways for itching in patients with atopic dermatitis?
The Editors' Choice Journal of Allergy and Clinical Immunology
Baochen Shi, PhD, Nathanael J
Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis  Eva Gros, MSc, Caroline Bussmann,
Eosinophilic esophagitis versus proton pump inhibitor–responsive esophageal eosinophilia: Transcriptome analysis  Tetsuo Shoda, MD, PhD, Akio Matsuda,
Pradeep Reddy Marri, PhD, Debra A. Stern, MS, Anne L
Food allergy is associated with Staphylococcus aureus colonization in children with atopic dermatitis  Andrea L. Jones, MD, Douglas Curran-Everett, PhD,
Bleomycin hydrolase downregulation in lesional skin of adult atopic dermatitis patients is independent of FLG gene mutations  Laurence Pellerin, PhD,
Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes  Matthew A. Tyler, MD, Chris B.
Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells  Shuo Li, PhD, Hideaki Morita, MD, PhD, Milena Sokolowska, MD, PhD,
Natural history of cow’s milk allergy
Increased immune reactivity to central nervous system–derived naturally presented peptides in patients with active multiple sclerosis  Christine Riedhammer,
Presentation transcript:

Relations between epidermal barrier dysregulation and Staphylococcus species– dominated microbiome dysbiosis in patients with atopic dermatitis  Can Altunbulakli, MSc, Matthias Reiger, PhD, Avidan U. Neumann, PhD, Natalie Garzorz-Stark, MD, Megan Fleming, MD, Claudia Huelpuesch, MSc, Francesc Castro-Giner, PhD, Kilian Eyerich, MD, Cezmi A. Akdis, MD, Claudia Traidl-Hoffmann, MD  Journal of Allergy and Clinical Immunology  Volume 142, Issue 5, Pages 1643-1647.e12 (November 2018) DOI: 10.1016/j.jaci.2018.07.005 Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 β-Diversity of the global skin microbiome and transcriptome. A and B, NMDS clustering of the skin microbiome separates healthy (HE) skin samples from samples from patients with AD (both lesional [LS] and nonlesional [NL] AD; Fig 1, A), whereas 2-component PCA clustering of the skin transcriptome (Fig 1, B) differentiates between skin samples form patients with lesional versus nonlesional AD and healthy skin; the latter 2 are not well differentiated. C, Staphylococcaceae is the only family that is significantly (P = .003) more abundant in samples from patients with AD, revealing Staphylococcus species–dominated dysbiosis. D, Heat map Gene Ontology (GO) analysis of the top 2000 significantly differentially expressed genes in patients with lesional versus nonlesional AD shows that cadherin signaling, adhesion molecules, and keratinization are among the most significant GO terms associated with AD. The most significant GO terms associated with 6 gene clusters in the top 2000 differentially expressed genes are presented with their P values and gene overlap numbers in the table. The scale for the NMDS distance (d) is presented in Fig 1, A, and the contribution of each principal component (PC) is presented in Fig 1, B. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Correlation between the frequency of Staphylococcus species and mRNA expression of TJ genes. A-D, An MTC-negative correlation is observed in lesional (LS; red) skin between S aureus frequency and the expression level of the TJ genes CLDN4 (Fig 2, A) and TJP1 (Fig 2, B), whereas MTC-positive correlation is observed between S epidermidis and the same genes (Fig 2, C and D). However, in nonlesional (NL) skin (blue) there is no correlation between Staphylococcus species and these TJ genes. The relation between lesional and nonlesional paired samples (dotted black lines) shows the same direction as the correlation between lesional samples for CLDN4 (Fig 2, A and C) but the inverse direction for TJP1 (Fig 2, B and D). E-H, In fact, in lesional skin all 4 major Staphylococcus species (S aureus in red, S epidermidis in light blue, S hominis in green, and S haemolyticus in purple) show correlation with CLDN4 (Fig 2, E) and TJP1 (Fig 2, F), as well as with CLDN5 (Fig 2, G) and TJP2 (Fig 2, H). Solid lines depict MTC correlations with ρ = 1 and P < .017. Dashed lines depict correlations with ρ > 0.8 and P < .05. Dash-dotted lines depict trends for correlations. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Schematics of study design and methodology. Swabs and biopsy specimens from the same skin area collected from patients with AD (n = 13) and healthy control subjects (n = 7) were processed, sequenced, and analyzed in parallel for global microbiome and transcriptomics. To reduce multiple testing, we then focused on Staphylococcus species on the one hand and skin barrier genes on the other hand for more detailed analysis and correlation. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 β-Diversity of global skin microbiome and transcriptome. A and B, NMDS clustering of the skin microbiome (Fig E2, A) separates healthy skin samples from those from patients with AD (both lesional and nonlesional AD) and, to a lesser extent, lesional from nonlesional samples, whereas 3-component PCA clustering (Fig E2, B) of skin transcriptome differentiates between all 3 skin groups. PC, Principal component. C-E, Hierarchical clustering of the global skin microbiome (Fig E2, C) separates AD lesional and nonlesional samples from healthy skin, with one exception, whereas for transcriptomics, the clustering of all genes (Fig E2, D) separates lesional samples from the others, but clustering of only the top 100 genes (Fig E2, E) separates all 3 skin groups. HE, Healthy; LS, lesional AD; NL, nonlesional AD. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 Different frequencies of Staphylococcus species. A and B, Frequencies of Staphylococcus species show different abundance patterns in healthy, lesional AD, and nonlesional AD skin, with only S aureus most abundant in AD lesional samples, whereas S epidermidis is most abundant in nonlesional skin, and the other species are most abundant in healthy skin. C and D, S aureus frequency is negatively correlated with that of S epidermidis and all other staphylococci, which are positively correlated with each other, in lesional skin. Heat map of fold change expression values (FCH) is scaled from blue to red in Fig E3, B, and heat map of correlation coefficients (R) is scaled from orange to green in Fig E3, D. HE, Healthy; LS, lesional AD; NL, nonlesional AD. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 Differential expression of skin barrier gene families. Epidermal barrier genes are the most significant differentially expressed Kyoto Encyclopedia of Genes and Genomes pathway group in the AD-related transcriptome (Table E3). A and C, Heat map clustering of TJ (Fig E4, A) and SC barrier (Fig E4, C) gene expression shows different patterns of differential expression. B, Most highly expressed TJ genes are significantly downregulated in lesional skin, whereas some TJ genes expressed at lower levels and in particular TJ adaptor genes (eg, TJP1) are upregulated in lesions. D, Among the SC genes, filaggrins are downregulated in AD skin compared with healthy skin and in particular in lesional skin, whereas the keratin genes show a mix of upregulation and downregulation in AD and lesional skin. HE, Healthy; LS, lesional AD; NL, nonlesional AD. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E5 Differential expression of skin barrier gene families. A-C, Heat map clustering of gene expression of GJ (Fig E5, A), desmosome (Fig E5, B), and AJ skin barrier genes (Fig E5, C) show a mixed pattern of differential expression. HE, Healthy; LS, lesional AD; NL, nonlesional AD. Journal of Allergy and Clinical Immunology 2018 142, 1643-1647.e12DOI: (10.1016/j.jaci.2018.07.005) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions